Viewing Study NCT03155893


Ignite Creation Date: 2025-12-25 @ 1:22 AM
Ignite Modification Date: 2026-01-27 @ 12:22 AM
Study NCT ID: NCT03155893
Status: COMPLETED
Last Update Posted: 2017-11-14
First Post: 2017-05-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Cardiac Safety of a Single Dose of AL-335 Administered on a Background of Simeprevir and Odalasvir and of Repeated Doses of Odalasvir Administered Alone in Healthy Participants
Sponsor: Janssen Research & Development, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module